DEVELOPMENT AND VALIDATION OF A COMPOSITE RISK SCORE FOR PREDICTING MULTIDRUG-RESISTANT INFECTIONS IN CRITICALLY ILL PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY

Background: Early identification of multidrug-resistant (MDR) infections in critically ill patients remains a major clinical challenge. Delayed recognition often leads to inappropriate empirical therapy, increased mortality, and escalation of antimicrobial resistance. Clinical prediction tools may facilitate early risk stratification and optimize antimicrobial decision-making. Objectives: To develop and internally validate a composite clinical risk score for predicting MDR infections in critically ill patients. Methods: A prospective observational study was conducted among 100 critically ill patients receiving antimicrobial therapy. Independent predictors identified through multivariable logistic regression were incorporated into a weighted risk score. Model performance was evaluated using ROC analysis, calibration testing, and diagnostic accuracy metrics. Results: MDR prevalence was 42%. Independent predictors included ≥5 antibiotics (aOR 3.41; p=0.005), ICU stay >8 days (aOR 2.89; p=0.019), Gram-negative infection (aOR 3.27; p=0.018), and diabetes mellitus (aOR 2.21; p=0.046). A composite 8-point risk score demonstrated increasing MDR probability across low (12%), moderate (41%), and high-risk groups (78%) (p<0.001). Model discrimination was good (AUROC 0.78), with stable bootstrap validation (0.77). Calibration was acceptable (Hosmer–Lemeshow p=0.62). Conclusion: The ICU-MDR Risk Score provides a practical bedside tool with good predictive performance for early identification of high-risk patients.

• Ventola CL The antibiotic resistance crisis: part 1: causes and threats Pharm Ther, 2015; 40(4):           277–283.
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria Clin Microbiol Infect, 2012; 18(3):            268–281. 
• Gajic I, et al Antimicrobial resistance in hospital settings Antibiotics, 2022; 11(4): 427. 
• Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, et al Challenges and research priorities to progress the impact of antimicrobial stewardship Drugs Context, 2019; 8: 212600. 
• Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med, 2021; 47(11): 1181–1247. 
• Kollef MH, Micek ST Antibiotic stewardship programs: mandatory for all ICUs Crit Care, 2012; 16(6): 179. 
• Fahim NAE Prevalence of multidrug-resistant organisms in ICU settings J Egypt Public Health Assoc., 2021; 96(1): 7. 
• Kumari A, et al Bacterial isolates and resistance trends in critical care units MedPulse Int J Pharmacol, 2019; 11(1): 21–24. 
• Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M Achieving global targets for antimicrobial resistance Science, 2016; 353(6302): 874–875. 
• Patil RH, et al Antimicrobial resistance patterns in ICU isolates Int J Pharm Sci Res., 2023; 14(8): 2371–2384. 
• Lat TI, et al Antibiotic resistance in ICU-acquired infections Clin Chest Med, 2021; 42(3): 543–555. 
• Girish I, Harish I Microbial profile and antibiogram in ICU patients J Evid Based Med Healthc, 2018; 5(10): 735–738. 
• Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al Burden of antibiotic-resistant infections in Europe Lancet Infect Dis., 2019; 19(1): 56–66. 
• Gajic I, et al Antimicrobial resistance in hospital settings Antibiotics, 2022; 11(4): 427. 
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al MDR definitions Clin Microbiol Infect, 2012; 18(3): 268–281. 
• Barlam TF, Cosgrove SE, Abbo LM, et al Implementing antimicrobial stewardship programs Clin Infect Dis., 2016; 62(10): e51–e77.
• Ventola CL Antibiotic resistance crisis Pharm Ther, 2015; 40(4): 277–283.
• Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al Surviving Sepsis Campaign guidelines Intensive Care Med, 2021; 47(11): 1181–1247.
• Kollef MH, Micek ST Antibiotic stewardship programs Crit Care, 2012; 16(6): 179. 
• Steyerberg EW Clinical Prediction Models Springer, 2019. 
• Collins GS, Reitsma JB, Altman DG, Moons KGM, et al TRIPOD statement Ann Intern Med, 2015; 162(1): 55–63. 
• Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M Achieving global targets for antimicrobial resistance Science, 2016; 353(6302): 874–875. 
• Bassetti M, Giacobbe DR, Vena A, et al Antimicrobial stewardship challenges Intensive Care Med, 2018; 44: 1461–1474.
• Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M Achieving global targets for antimicrobial resistance Science, 2016; 353(6302): 874–875. 
• Bassetti M, Giacobbe DR, Vena A, et al Antimicrobial stewardship and resistance control strategies in critical care settings Intensive Care Med, 2018; 44: 1461–1474.